Today: 11 June 2026
Walmart stock today: WMT slips after app outage; SEC filings spotlight insider sales and trading plans
30 December 2025
2 mins read

Walmart stock today: WMT slips after app outage; SEC filings spotlight insider sales and trading plans

NEW YORK, December 30, 2025, 17:16 ET — After-hours.

  • Walmart shares were down about 0.5% in after-hours trading after a brief online outage earlier in the day.
  • Customers reported problems with the Walmart app and website, including checkout issues, before service was restored.
  • Investors are also parsing fresh SEC filings on insider transactions and looking ahead to Jan. 13 and Feb. 19 company events.

Walmart Inc (WMT) shares were down 0.5% at $111.92 in after-hours trading on Tuesday. The stock traded between $111.85 and $112.68 in the regular session, with about 11.7 million shares changing hands.

The move comes during the year-end stretch when volumes tend to thin out and single headlines can sway sentiment. For Walmart, the focus is on execution heading out of the holiday period and into its fiscal fourth-quarter reporting window.

A brief disruption in online service matters because Walmart’s growth plan increasingly runs through digital ordering and delivery. Any checkout interruption — even short-lived — can raise fresh questions about systems resilience at a time when shoppers are returning gifts and redeeming promotions.

Outage-tracking site Downdetector logged more than 6,600 reports shortly after 7 a.m. ET, with users citing app problems and checkout issues. Walmart’s support account on X urged troubleshooting steps such as reinstalling the app or clearing cache and cookies, while a company spokesperson said systems were quickly restored.

The broader retail tape was also soft. The SPDR S&P Retail ETF was down about 0.7% in late trading, while Target was down 0.7% and Amazon was up 0.2%.

Investors also digested a set of fresh insider disclosures. A Form 4 published on Monday showed Walmart CEO Doug McMillon sold 19,416 shares at an average price of $111.8262, with the filing indicating the trade was under a Rule 10b5-1 plan — a pre-arranged trading program intended to limit the risk of trading on material non-public information.

In a separate 8-K filing, Walmart said Sam’s Club U.S. chief Chris Nicholas adopted a Rule 10b5-1 plan that schedules sales of 2,900 shares each month from April 2026 through March 2027, or up to 34,800 shares. The company said Nicholas will have no discretion over the timing of trades under the plan.

A Form 144 filing published Monday also showed the Walton Family Foundation, Inc. filed notice for a proposed sale of 88,000 Walmart shares with an aggregate market value of about $9.8 million, with Goldman Sachs & Co. LLC listed as broker. Form 144 filings disclose an intent to sell stock under SEC Rule 144 and do not, on their own, confirm a completed sale.

Macro signals remain in the mix for consumer names, with investors weighing the interest-rate outlook and its effect on spending. “The valuation gap is so wide, it absolutely is justified to see repositioning,” said Mark Hackett, chief market strategist at Nationwide, as U.S. stocks ended slightly lower and investors parsed Federal Reserve meeting minutes. Reuters

The next scheduled Walmart appearance on investors’ calendars is the ICR Conference on Jan. 13, when Daniel Danker, the company’s EVP of AI Acceleration, Product and Design, is set to take part in a fireside chat, according to Walmart’s events page.

Walmart is scheduled to report fiscal 2026 fourth-quarter results on Feb. 19 at 7 a.m. CT, the company said. Traders typically watch U.S. comparable sales, e-commerce momentum and margin trends coming out of the holiday quarter, along with guidance for the new fiscal year.

For now, the muted move suggests investors see the outage as contained, while monitoring whether the company flags any knock-on impact. With year-end positioning still in play, Walmart’s next catalysts are likely to come from its January conference remarks and February earnings rather than from day-to-day trading noise.

Stock Market Today

  • AMD Stock Price Forecast: Analyst Lowers Target Amid AI Market Caution
    June 11, 2026, 11:00 AM EDT. Shares of Advanced Micro Devices (AMD) have surged 111% year-to-date, driven by investor optimism over its expanding role in the artificial intelligence (AI) sector. Despite the strong performance, a prominent AI-focused analyst has trimmed the price target for AMD, signaling caution about the chipmaker's near-term prospects. The analyst cited concerns over competitive pressures and potential market saturation. AMD's growth is largely tied to its ability to capture demand in AI computing, a fast-evolving field requiring specialized semiconductor technology. Investors are weighing the company's robust sales against risks from supply chain constraints and intensifying industry competition.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake
Previous Story

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake

Rivian stock drops 5% after CEO share-sale filing as year-end trading thins
Next Story

Rivian stock drops 5% after CEO share-sale filing as year-end trading thins

Go toTop